ESC Premium Access

Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort study.

Congress Presentation

About the speaker

Doctor Casper Binding

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

9 more presentations in this session

Sex differences in admission rates, use of anticoagulation, and outcomes for emergency department presentations of atrial fibrillation

Speaker: Mr P. Daniele (Vancouver, CA)


Stroke and bleeding in low, intermediate and high risk patients with atrial fibrillation treated with edoxaban: Results of the ETNA-AF Europe registry

Speaker: Professor J. De Groot (Amsterdam, NL)


Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study

Speaker: Assistant Professor H. Yu (Seoul, KR)


Factors associated with inappropriate under-dosing of non-vitamin k antagonist oral anticoagulants (NOACs) by labelling criterion in patients with non-valvular atrial fibrillation in the UK

Speaker: Doctor A. Ruigomez (Madrid, ES)


New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation

Speaker: Doctor T. Nakano (Hiroshima, JP)


Access the full session

Poster Session 5 - Atrial fibrillation and oral anticoagulation 2

Speakers: Doctor C. Binding, Mr P. Daniele, Professor J. De Groot, Assistant Professor H. Yu, Doctor A. Ruigomez...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb